Home » Topics » BioWorld Science

BioWorld Science
RSS

TC BioPharm conducting phase I study of TCB-002 in AML

April 24, 2019

MET/SRC/CSF-1R inhibitor TPX-0022 shows antitumor activity, IND planned

April 24, 2019

FDA approves Skyrizi for moderate to severe plaque psoriasis

April 24, 2019

Tiziana's phase IIa trial of milciclib in advanced liver cancer passes interim safety review

April 24, 2019

Teva discontinues development of fremanezumab for cluster headaches

April 24, 2019

Innovent begins phase I trial of PD-1/PD-L1 bispecific antibody IBI-318

April 24, 2019

Takeda communicates data on ART-648 in preclinical models of NASH

April 24, 2019

Preclinical characterization detailed for phase I cancer candidate S-64315/MIK-665

April 24, 2019

Fujifilm presents new antibacterials

April 24, 2019

Beijing Yuezhikangtai Biomedicines identifies hedgehog-signaling inhibitors

April 24, 2019

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...